These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38698265)

  • 1. Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis.
    Ma J; Chen Y; Li T; Cao Y; Hu B; Liu Y; Zhang Y; Li X; Liu J; Zhang W; Niu H; Gao J; Zhang Z; Yue K; Wang J; Bao G; Wang C; Wang PG; Zou T; Xie S
    Oncogene; 2024 Jun; 43(25):1930-1940. PubMed ID: 38698265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo.
    Cuende J; Liénart S; Dedobbeleer O; van der Woning B; De Boeck G; Stockis J; Huygens C; Colau D; Somja J; Delvenne P; Hannon M; Baron F; Dumoutier L; Renauld JC; De Haard H; Saunders M; Coulie PG; Lucas S
    Sci Transl Med; 2015 Apr; 7(284):284ra56. PubMed ID: 25904740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.
    Huygens C; Liénart S; Dedobbeleer O; Stockis J; Gauthy E; Coulie PG; Lucas S
    J Biol Chem; 2015 Aug; 290(33):20105-16. PubMed ID: 26126825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.
    de Streel G; Bertrand C; Chalon N; Liénart S; Bricard O; Lecomte S; Devreux J; Gaignage M; De Boeck G; Mariën L; Van De Walle I; van der Woning B; Saunders M; de Haard H; Vermeersch E; Maes W; Deckmyn H; Coulie PG; van Baren N; Lucas S
    Nat Commun; 2020 Sep; 11(1):4545. PubMed ID: 32917858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
    Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.
    Gaignage M; Zhang X; Stockis J; Dedobbeleer O; Michiels C; Cochez P; Dumoutier L; Coulie PG; Lucas S
    Cancer Immunol Immunother; 2022 Aug; 71(8):1851-1862. PubMed ID: 34973084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Garp as a therapeutic target for modulation of T regulatory cell function.
    Shevach EM
    Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
    Li Y; Kim BG; Qian S; Letterio JJ; Fung JJ; Lu L; Lin F
    J Immunol; 2015 Sep; 195(6):2648-56. PubMed ID: 26246140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation.
    Edwards JP; Fujii H; Zhou AX; Creemers J; Unutmaz D; Shevach EM
    J Immunol; 2013 Jun; 190(11):5506-15. PubMed ID: 23645881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance.
    Edwards JP; Hand TW; Morais da Fonseca D; Glass DD; Belkaid Y; Shevach EM
    Eur J Immunol; 2016 Jun; 46(6):1480-9. PubMed ID: 27062243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GARP is regulated by miRNAs and controls latent TGF-β1 production by human regulatory T cells.
    Gauthy E; Cuende J; Stockis J; Huygens C; Lethé B; Collet JF; Bommer G; Coulie PG; Lucas S
    PLoS One; 2013; 8(9):e76186. PubMed ID: 24098777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo.
    Zhou AX; Kozhaya L; Fujii H; Unutmaz D
    J Immunol; 2013 May; 190(10):5057-64. PubMed ID: 23576681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
    Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S
    Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β1 in regulatory T cell biology.
    Moreau JM; Velegraki M; Bolyard C; Rosenblum MD; Li Z
    Sci Immunol; 2022 Mar; 7(69):eabi4613. PubMed ID: 35302863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Blockade of GARP:TGF-β1 and PD-1 Increases Infiltration of T Cells and Density of Pericyte-Covered GARP
    Bertrand C; Van Meerbeeck P; de Streel G; Vaherto-Bleeckx N; Benhaddi F; Rouaud L; Noël A; Coulie PG; van Baren N; Lucas S
    Front Immunol; 2021; 12():704050. PubMed ID: 34386010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of GARP in the activation of latent TGF-β1.
    Stockis J; Dedobbeleer O; Lucas S
    Mol Biosyst; 2017 Sep; 13(10):1925-1935. PubMed ID: 28795730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis.
    Lecomte S; Devreux J; de Streel G; van Baren N; Havelange V; Schröder D; Vaherto N; Vanhaver C; Vanderaa C; Dupuis N; Pecquet C; Coulie PG; Constantinescu SN; Lucas S
    Blood; 2023 Feb; 141(5):490-502. PubMed ID: 36322928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of active TGF-β1 from the latent TGF-β1/GARP complex on T regulatory cells is mediated by integrin β8.
    Edwards JP; Thornton AM; Shevach EM
    J Immunol; 2014 Sep; 193(6):2843-9. PubMed ID: 25127859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA.
    Dedobbeleer O; Stockis J; van der Woning B; Coulie PG; Lucas S
    J Immunol; 2017 Jul; 199(2):391-396. PubMed ID: 28607112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-GARP Antibodies Inhibit Release of TGF-β by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In Vitro.
    Igney FH; Ebenhoch R; Schiele F; Nar H
    Immunohorizons; 2023 Mar; 7(3):200-212. PubMed ID: 36928178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.